Skip to content

Combination of magnetic ovoid-tip needle and shi’s fire needle for string instrumentalists’ shoulder arthralgia

Combination of magnetic ovoid-tip needle and shi’s fire needle for string instrumentalists’ shoulder arthralgia

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400088745
Enrollment
Unknown
Registered
2024-08-26
Start date
2023-08-01
Completion date
Unknown
Last updated
2024-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Musculoskeletal disorders

Interventions

control group:Filiform needle group
experimental group 1:Shi’s fine Fire needle group
experimental group 2:Magnetic ovoid-tip needle group
experimental group 3:Magnetic ovoid-tip needle combined with Fire needle group

Sponsors

Shanxi Provincial Administration of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 79 Years

Inclusion criteria

Inclusion criteria: a. String instrument major who meet the Chinese or Western diagnostic criteria for frozen shoulder and have a confirmed diagnosis of frozen shoulder with all vital signs stable; b. Persons with periarthritis of shoulder due to repetitive strain injury associated with playing a string instrument; c. Persons of any gender, aged between 18 and 79 years; d. Persons with significant limitation of both active and passive shoulder movements (e.g. abduction and flexion and extension not exceeding 90°, external rotation not exceeding 30°, painful symptoms > VAS 5); e. Those who have not been treated with other methods within 1 week prior to the consultation; f. Patients who are conscious, can understand the relevant content of the scale, have good expressive skills and are cooperative with the treatment; g. Good compliance, voluntary participation and signed informed consent form.

Exclusion criteria

Exclusion criteria: a. Anyone who does not meet the inclusion criteria and cannot cooperate with the arrangement of the treatment programme; b. Shoulder dislocation, shoulder tuberculosis, septic shoulder arthritis, shoulder tumours, heart, gall bladder and other organ disorders reflex shoulder pain; c. A history of shoulder trauma, shoulder pain caused by related surgery or cervical spondylosis; d. Those with severe cardiovascular disease, liver or kidney impairment, immune deficiency, mental disorder, diabetes mellitus or blood disorders; e. Persons with local skin infection, deep swelling, subcutaneous ecchymosis, or fractures in the area where the procedure was performed; f. Patients who cannot understand the content of the scale, who are unconscious or unable to express subjective symptoms of discomfort, and who are unable to evaluate the efficacy of the treatment; g. Pregnant women, breastfeeding, allergic persons, persons younger than 18 years and older than 80 years; h. Those who have poor compliance with treatment, or who receive other treatments during treatment that may interfere with the observation of efficacy.

Design outcomes

Primary

MeasureTime frame
DASH;VAS;

Secondary

MeasureTime frame
FPX analgesic;

Countries

China

Contacts

Public ContactYanrong Song,Tiansheng Zhang

Shanxi Provincial Acupuncture Hospital

282773572@qq.com+86 133 0351 6016

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026